---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-034601"
form_type: "8-K"
ticker: "OTLK"
cik: "0001649989"
company_name: "Outlook Therapeutics, Inc."
filed_at: "2026-03-25T23:59:59+00:00"
generated_at: "2026-05-15T09:01:34.604238+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Outlook Therapeutics closes $5.0M offering of common stock and warrants

## Summary
- 20M shares + 20M warrants sold at $0.25/unit; gross proceeds ~$5.0M, net ~$4.0M.
- Warrants exercisable immediately at $0.25, expire in 5 years; includes 4.99%/9.99% beneficial ownership limitation.
- H.C. Wainwright placement agent, receiving 7% cash fee and 1.4M warrants at $0.3125.
- Company agreed to one-year ban on variable rate transactions and lock-up agreements.
- Offering closed March 25, 2026; net proceeds ~$4.0M for general corporate purposes.

## SEC filing metadata
- accession: 0001104659-26-034601
- form_type: 8-K
- ticker: OTLK
- cik: 0001649989
- company_name: Outlook Therapeutics, Inc.
- filed_at: 2026-03-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649989/000110465926034601/0001104659-26-034601-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649989/000110465926034601/tm269822d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-034601
- JSON: https://secwatch.observer/filing/0001104659-26-034601.json
- Plain text: https://secwatch.observer/filing/0001104659-26-034601.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.